Short Active Lives Survey in Chronic Lung Conditions
Short Active Lives Survey in Chronic Lung Conditions: an Exploratory Study
Short Actives Lives Survey is a common tool used to measure physical activity in the UK population. Self-reported measures such as the Short Active Lives Survey can be prone to bias. As such, during project evaluations, benefits may be exaggerated due to over-reporting of physical activity or downplayed due to underreporting of physical activity. There is also a lack of research reporting the typical short-term and long-term changes in physical activity (measured by the Short Active Lives Survey) in people with chronic lung conditions who are not receiving support to become active (i.e. usual care, control groups). Accelerometers are small lightweight activity monitors that can be worn on the waist. These monitors are known to provide accurate and reliable objective assessment of physical activity in people with lung conditions.
This research study will recruit a cohort of inactive people with lung conditions and determine changes in physical activity measured by both the Short Active Lives Survey and one of the most valid accelerometers used in people with lung conditions (Actigraph GT3X). The study will also evaluate how these physical activity measures relate to general health (health status and health care use) of people with lung conditions over 12 months. This study will provide information on the usefulness of using the Short Active Lives Survey in the future for measuring physical activity in people with lung conditions.
調査の概要
状態
条件
研究の種類
入学 (実際)
連絡先と場所
研究場所
-
-
Lincolnshire
-
Lincoln、Lincolnshire、イギリス、LN6 7TS
- University of Lincoln
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
サンプリング方法
調査対象母集団
説明
Inclusion Criteria:
- Diagnosis of Chronic Obstructive Pulmonary Disease, Bronchiectasis, Interstitial Lung Disease, Lung Cancer, Mesothelioma or Asthma
- Physically inactive defined as completing less than 30 minutes ore more of moderate intensity equivalent physical activity per week (measured by the Short Active Lives Survey)
Exclusion Criteria:
- Adults without a diagnosis of Chronic Obstructive Pulmonary Disease, Bronchiectasis, Interstitial Lung Disease, Lung Cancer, Mesothelioma or Asthma
- Age < 18 Years
- Completing 30 minutes or more of moderate intensity equivalent (MIE) physical activity per week
- Inability or unwillingness to sign informed consent
研究計画
研究はどのように設計されていますか？
デザインの詳細
コホートと介入
グループ/コホート |
|---|
|
Usual Care
People with a chronic lung condition who are physically inactive
|
この研究は何を測定していますか？
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Minutes of self-reported moderate intensity equivalent physical activity per week
時間枠：Baseline to 12 months
|
Short Active Lives Survey
|
Baseline to 12 months
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Accelerometer measured physical activity: time (minutes per day) spent in moderate intensity activity
時間枠：Baseline to 12 months
|
Actigraph wGT3X-BT
|
Baseline to 12 months
|
|
Accelerometer measured physical activity: time (minutes per week) spent in light activity
時間枠：Baseline to 12 months
|
Actigraph wGT3X-BT
|
Baseline to 12 months
|
|
Accelerometer measured physical activity including: time (minutes per week) spent in vigorous activity
時間枠：Baseline to 12 months
|
Actigraph wGT3X-BT
|
Baseline to 12 months
|
|
Accelerometer measured physical activity: time (minutes per day) spent in sedentary state
時間枠：Baseline to 12 months
|
Actigraph wGT3X-BT
|
Baseline to 12 months
|
|
Accelerometer measured physical activity: average daily steps
時間枠：Baseline to 12 months
|
Actigraph wGT3X-BT
|
Baseline to 12 months
|
|
Accelerometer measured physical activity including: daily vector magnitude units
時間枠：Baseline to 12 months
|
Actigraph wGT3X-BT
|
Baseline to 12 months
|
|
EQ5D index
時間枠：Baseline to 12 months
|
Based on self-rating of five dimensions (mobility, self-care, usual activities, pain/discomfort, anxiety/depression).
Each dimension is rated between 1 (no problems) to 5 (unable to/extreme problems).
Dimensions are combined to produce a five-digit number describing the individual's health status (ranging from 11111 to 55555).
Five digit number converted to an index based on the EQ-5D-5L value set for England.
Index ranges from -0.208 (worst possible health) to 1.000 (best possible health).
|
Baseline to 12 months
|
|
EQ VAS
時間枠：Baseline to 12 months
|
Self-report of health status on a scale, 0 (worst health) - 100 (best health)
|
Baseline to 12 months
|
|
Cost questionnaire
時間枠：Baseline to 12 months
|
NHS resource use questionnaire
|
Baseline to 12 months
|
|
Demographics:
時間枠：Baseline to 12 months
|
Age, gender, ethnicity, comorbidities, social deprivation, MRC degree of breathlessness, oxygen use
|
Baseline to 12 months
|
協力者と研究者
スポンサー
捜査官
- 主任研究者：Arwel W Jones, PhD、University of Lincoln
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。
肺疾患の臨床試験
-
Taichung Veterans General Hospital完了心毒性 | 非小細胞肺癌（MeSH用語：Carcinoma, Non-Small-Cell Lung） | 薬物関連の副作用および有害反応（MeSH用語） | EGFRチロシンキナーゼ阻害剤台湾
-
Fondazione del Piemonte per l'Oncologia募集乳がん | 卵巣がん | 結腸直腸がん | 黒色腫 (皮膚がん) | 非小細胞肺癌（MeSH用語：Carcinoma, Non-Small-Cell Lung）イタリア